Given that MINDIN induces osteomimicry in prostate cancer cells [18] and regulates bone processes during premetastatic development [19], we hypothesize that regulation of NHERF-1 is one of the mechanisms used by MINDIN during prostate progression towards a bone metastatic phenotype. Here, SPON2 is linked to urogenital neoplasm.